ASX · CBA.AX
Commonwealth Bank of Australia
A$166.72+A$0.33 (+0.2%)
Commonwealth Bank of Australia’s quoted price sits in the upper half of its reported 52-week range, 10.17% below the high.
Loading market information…
ASX · NOL.AX · AUD
Stock price, earnings
Quote as of Oct 30, 2026, 05:10 AM UTC. Cached market data; not a live quote.
One-year closing-price history · AUD. Historical prices are not a forecast.
NobleOak Life Limited’s quoted price sits in the upper half of its reported 52-week range, 10.03% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
NobleOak Life Limited’s next earnings report is currently expected on Feb 26, 2027. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow NobleOak Life Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
NobleOak Life Limited engages in underwriting life insurance products in Australia. It offers life, income protection, total and permanent disability, death, trauma, business expenses, and self-managed super fund insurance plans. The company sells its insurance products through direct-to-market and strategic partner channels. The company was formerly known as United Ancient Order of Druids Friendly Society of NSW and changed its name to NobleOak Life Limited in 2011. NobleOak Life Limited was founded in 1861 and is headquartered in Sydney, Australia.
Latest available per-share figures in AUD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:51 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| A$169.57M0.0% vs estimate |
| Q4 2023 | Aug 30, 2023 | A$0.09 | A$171.04M-52.41% vs estimate |
|---|
| Q2 2023 | Feb 27, 2023 | A$0.06+1.48% vs estimate | A$164.31M+11.4% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
A$166.72+A$0.33 (+0.2%)
Commonwealth Bank of Australia’s quoted price sits in the upper half of its reported 52-week range, 10.17% below the high.
A$41.51+A$0.15 (+0.36%)
National Australia Bank Limited’s quoted price sits in the lower half of its reported 52-week range, 16.06% below the high.
A$36.82-A$0.39 (-1.05%)
Westpac Banking Corporation’s quoted price sits in the lower half of its reported 52-week range, 15.0% below the high.
A$40.81+A$0.09 (+0.22%)
ANZ Group Holdings Limited’s quoted price sits in the upper half of its reported 52-week range, 1.26% below the high.
A$105.50-A$0.05 (-0.05%)
Australia and New Zealand Banking Group Ltd’s quoted price sits in the upper half of its reported 52-week range, 2.75% below the high.
A$5.09+A$0.08 (+1.6%)
Medibank Private Limited’s quoted price sits in the upper half of its reported 52-week range, 4.14% below the high.
A$12.02+A$0.04 (+0.33%)
Challenger Limited’s quoted price sits in the upper half of its reported 52-week range, 0.83% below the high.
A$3.10-A$0.05 (-1.59%)
Generation Development Group Limited’s quoted price sits in the lower half of its reported 52-week range, 58.28% below the high.
